Corcept Therapeutics | CORT - Market Capitalization


Corcept Therapeutics reported $4.27B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
ANI Pharmaceuticals USD 2.04B 630M Sep/2025
Ardelyx USD 1.33B 390M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 8.76B 977M Sep/2025
Eli Lilly USD 722.15B 16.64B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
TG Therapeutics USD 5.74B 21M Sep/2025